{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:22:37Z","timestamp":1793197357775,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Taif University, Saudi Arabia","award":["TU-DSPP-2024-54"],"award-info":[{"award-number":["TU-DSPP-2024-54"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03996-w","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:27:16Z","timestamp":1762352836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic significance of dipeptidyl peptidase-7 (DPP7) in HPV16-negative head and neck squamous cell carcinoma treated with induction chemoradiotherapy"],"prefix":"10.1007","volume":"16","author":[{"given":"Amal F.","family":"Gharib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haytham","family":"Dahlawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5161-9987","authenticated-orcid":false,"given":"Shereen El","family":"Tarhouny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermin","family":"Raafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Khalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalya A.","family":"Iskandarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"Saber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael H.","family":"Elsawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"issue":"1","key":"3996_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Reviews Disease Primers. 2020;6(1):92.","journal-title":"Nat Reviews Disease Primers"},{"key":"3996_CR2","doi-asserted-by":"crossref","unstructured":"Sharma S, Upadhyay AK, Prakash A, Singodia P, Kiran SR, Shankar R. Treatment complications of head and neck cancers and rehabilitation measures: A narrative review. Cureus. 2024;16(5):e61173","DOI":"10.7759\/cureus.61173"},{"key":"3996_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-020-07773-6","volume":"21","author":"C Hammerm\u00fcller","year":"2021","unstructured":"Hammerm\u00fcller C, Hinz A, Dietz A, Wichmann G, Pirlich M, Berger T, et al. Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population. BMC Cancer. 2021;21:1\u201311.","journal-title":"BMC Cancer"},{"issue":"1","key":"3996_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s44178-024-00098-5","volume":"3","author":"P Han","year":"2024","unstructured":"Han P, Liang F, Song P, Wu T, Li Y, Gao M, et al. Neoadjuvant programmed cell death 1 Blockade combined with chemotherapy for locally advanced head and neck squamous cell carcinoma. Holist Integr Oncol. 2024;3(1):31.","journal-title":"Holist Integr Oncol"},{"key":"3996_CR5","doi-asserted-by":"publisher","first-page":"1364799","DOI":"10.3389\/fimmu.2024.1364799","volume":"15","author":"S-G Wu","year":"2024","unstructured":"Wu S-G, Wang R-J, Zhou Y, Luo X-Y. Neoadjuvant therapy with chemotherapy and immune checkpoint inhibitor for laryngeal function preservation in locally advanced hypopharyngeal cancer. Front Immunol. 2024;15:1364799.","journal-title":"Front Immunol"},{"issue":"19","key":"3996_CR6","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.3390\/cancers13194912","volume":"13","author":"G Anderson","year":"2021","unstructured":"Anderson G, Ebadi M, Vo K, Novak J, Govindarajan A, Amini A. An updated review on head and neck cancer treatment with radiation therapy. Cancers. 2021;13(19):4912.","journal-title":"Cancers"},{"issue":"3","key":"3996_CR7","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3390\/cancers15030590","volume":"15","author":"A Berger","year":"2023","unstructured":"Berger A, Perrod G, Pioche M, Barret M, Cesbron-M\u00e9tivier E, L\u00e9pilliez V, et al. Efficacy of organ preservation strategy by adjuvant chemoradiotherapy after non-curative endoscopic resection for superficial SCC: a multicenter Western study. Cancers. 2023;15(3):590.","journal-title":"Cancers"},{"key":"3996_CR8","doi-asserted-by":"crossref","unstructured":"Sharon S, Bell RB. Immunotherapy in head and neck squamous cell carcinoma: a narrative review. Front Oral Maxillofacial Med. 2022;4:28.","DOI":"10.21037\/fomm-21-48"},{"key":"3996_CR9","doi-asserted-by":"publisher","first-page":"868490","DOI":"10.3389\/fonc.2022.868490","volume":"12","author":"CM Black","year":"2022","unstructured":"Black CM, Keeping S, Mojebi A, Ramakrishnan K, Chirovsky D, Upadhyay N, et al. Correlation between early Time-to-Event outcomes and overall survival in patients with locally advanced head and neck squamous cell carcinoma receiving definitive chemoradiation therapy: systematic review and Meta-Analysis. Front Oncol. 2022;12:868490.","journal-title":"Front Oncol"},{"issue":"18","key":"3996_CR10","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1002\/cncr.34823","volume":"129","author":"CT Haring","year":"2023","unstructured":"Haring CT, Kana LA, Dermody SM, Brummel C, McHugh JB, Casper KA, et al. Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols. Cancer. 2023;129(18):2817\u201327.","journal-title":"Cancer"},{"key":"3996_CR11","doi-asserted-by":"publisher","first-page":"1269863","DOI":"10.3389\/fphar.2023.1269863","volume":"14","author":"H Wang","year":"2023","unstructured":"Wang H, Zheng Z, Zhang Y, Bian C, Bao J, Xin Y, et al. Locally advanced head and neck squamous cell carcinoma treatment efficacy and safety: a systematic review and network meta-analysis. Front Pharmacol. 2023;14:1269863.","journal-title":"Front Pharmacol"},{"key":"3996_CR12","doi-asserted-by":"publisher","first-page":"1002871","DOI":"10.3389\/fphar.2022.1002871","volume":"13","author":"C Cui","year":"2022","unstructured":"Cui C, Tian X, Wei L, Wang Y, Wang K, Fu R. New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors. Front Pharmacol. 2022;13:1002871.","journal-title":"Front Pharmacol"},{"issue":"7","key":"3996_CR13","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3390\/diagnostics11071204","volume":"11","author":"T-K Choy","year":"2021","unstructured":"Choy T-K, Wang C-Y, Phan NN, Khoa Ta HD, Anuraga G, Liu Y-H, et al. Identification of dipeptidyl peptidase (DPP) family genes in clinical breast cancer patients via an integrated bioinformatics approach. Diagnostics. 2021;11(7):1204.","journal-title":"Diagnostics"},{"issue":"10","key":"3996_CR14","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.3390\/plants11101330","volume":"11","author":"A Baharin","year":"2022","unstructured":"Baharin A, Ting T-Y, Goh H-H. Post-proline cleaving enzymes (PPCEs): classification, structure, molecular properties, and applications. Plants. 2022;11(10):1330.","journal-title":"Plants"},{"issue":"1","key":"3996_CR15","doi-asserted-by":"publisher","first-page":"e00452","DOI":"10.14309\/ctg.0000000000000452","volume":"13","author":"SE Jaenisch","year":"2022","unstructured":"Jaenisch SE, Abbott CA, Gorrell MD, Bampton P, Butler RN, Yazbeck R. Circulating dipeptidyl peptidase activity is a potential biomarker for inflammatory bowel disease. Clin Translational Gastroenterol. 2022;13(1):e00452.","journal-title":"Clin Translational Gastroenterol"},{"issue":"7","key":"3996_CR16","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3390\/cancers13071527","volume":"13","author":"JJ Miettinen","year":"2021","unstructured":"Miettinen JJ, Kumari R, Traustadottir GA, Huppunen M-E, Sergeev P, Majumder MM, et al. Aminopeptidase expression in multiple myeloma associates with disease progression and sensitivity to Melflufen. Cancers. 2021;13(7):1527.","journal-title":"Cancers"},{"issue":"15","key":"3996_CR17","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.3390\/ijms20153818","volume":"20","author":"P Ahluwalia","year":"2019","unstructured":"Ahluwalia P, Mondal AK, Bloomer C, Fulzele S, Jones K, Ananth S, et al. Identification and clinical validation of a novel 4 gene-signature with prognostic utility in colorectal cancer. Int J Mol Sci. 2019;20(15):3818.","journal-title":"Int J Mol Sci"},{"issue":"16","key":"3996_CR18","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.7150\/jca.93112","volume":"15","author":"L Ma","year":"2024","unstructured":"Ma L, Yang H, Wu S, Wang C, Mei J. DPP7 as a potential therapeutic marker for colorectal cancer. J Cancer. 2024;15(16):5425.","journal-title":"J Cancer"},{"key":"3996_CR19","doi-asserted-by":"publisher","first-page":"1200017","DOI":"10.3389\/fphar.2023.1200017","volume":"14","author":"J Chen","year":"2023","unstructured":"Chen J, Wu S, Peng Y, Zhao Y, Dong Y, Ran F, et al. Constructing a cancer stem cell related prognostic model for predicting immune landscape and drug sensitivity in colorectal cancer. Front Pharmacol. 2023;14:1200017.","journal-title":"Front Pharmacol"},{"key":"3996_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11912-019-0799-x","volume":"21","author":"DK Zanoni","year":"2019","unstructured":"Zanoni DK, Patel SG, Shah JP. Changes in the 8th edition of the American joint committee on cancer (AJCC) staging of head and neck cancer: rationale and implications. Curr Oncol Rep. 2019;21:1\u20137.","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"3996_CR21","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1159\/000503095","volume":"12","author":"F Azam","year":"2020","unstructured":"Azam F, Latif MF, Farooq A, Tirmazy SH, AlShahrani S, Bashir S, et al. Performance status assessment by using ECOG (Eastern cooperative oncology Group) score for cancer patients by oncology healthcare professionals. Case Rep Oncol. 2020;12(3):728\u201336.","journal-title":"Case Rep Oncol"},{"key":"3996_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-08944-9","volume":"21","author":"P Xie","year":"2021","unstructured":"Xie P, Zheng H, Chen H, Wei K, Pan X, Xu Q, et al. Tumor response as defined by iRECIST in Gastrointestinal malignancies treated with PD-1 and PD-L1 inhibitors and correlation with survival. BMC Cancer. 2021;21:1\u201310.","journal-title":"BMC Cancer"},{"issue":"2","key":"3996_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s40487-023-00226-7","volume":"11","author":"S Zheng","year":"2023","unstructured":"Zheng S, Feng Y, Li C, Zhang J, Xie K. Induction therapy for locally advanced head and neck squamous cell carcinoma. Oncol Therapy. 2023;11(2):185\u201398.","journal-title":"Oncol Therapy"},{"issue":"2","key":"3996_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/jjco\/hyaa220","volume":"51","author":"S Okano","year":"2021","unstructured":"Okano S, Homma A, Kiyota N, Tahara M, Hanai N, Asakage T, et al. Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck. Jpn J Clin Oncol. 2021;51(2):173\u20139.","journal-title":"Jpn J Clin Oncol"},{"issue":"31","key":"3996_CR25","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1200\/JCO.2017.76.2591","volume":"36","author":"L Geoffrois","year":"2018","unstructured":"Geoffrois L, Martin L, De Raucourt D, Sun XS, Tao Y, Maingon P, et al. Induction chemotherapy followed by cetuximab radiotherapy is not superior to concurrent chemoradiotherapy for head and neck carcinomas: results of the GORTEC 2007-02 phase III randomized trial. J Clin Oncol. 2018;36(31):3077\u201383.","journal-title":"J Clin Oncol"},{"issue":"15","key":"3996_CR26","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.3390\/cancers15153954","volume":"15","author":"W Zhang","year":"2023","unstructured":"Zhang W, Wang H, Wang H, Xu C, Zhao R, Yao J, et al. Integrated analysis identifies DPP7 as a prognostic biomarker in colorectal cancer. Cancers. 2023;15(15):3954.","journal-title":"Cancers"},{"key":"3996_CR27","doi-asserted-by":"publisher","unstructured":"Sariman M, Yaylaz BS, Ayer M, Ekmekci SS, Suer I, Cefle K et al. TMED9 is a predictive marker of transition from monoclonal gammopathy of undetermined significance to multiple myeloma. 2022. Research Square. https:\/\/doi.org\/10.21203\/rs.3.rs-2370302\/v1.","DOI":"10.21203\/rs.3.rs-2370302\/v1"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03996-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03996-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03996-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T10:37:20Z","timestamp":1762511840000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03996-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3996"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03996-w","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been updated to correct the acknowledgement.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are accountable for all aspects of the work in ensuring that accuracy and integrity of any part of the work are appropriately investigated and resolved. This study was conducted in accordance with the Helsinki Declaration (revised in 2013). The study was approved by the Research Ethics Committee of Faculty of Medicine, Zagazig University (No. 112: 2016-Jan). Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors confirm they have read and approved the final manuscript. The work has not been published previously, is not under consideration elsewhere, and contains no previously published material by any author. All authors agree to submission to Discover Oncology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2046"}}